IRAK3 and Sepsis: Clinical samples of sepsis patients show increased IRAK3 mRNA levels and significant decreases in TNF-α and IL-6 protein levels at 4h (IT) after ex vivo LPS challenge [89] or decreased TNF-α protein levels at IT or LT [88], whereas samples from healthy controls demonstrate the hyper-inflammatory phase of sepsis.